What Japan’s New Compliance Code Means for Pharma
Japan is adding the Product Information Offering Activities of Ethical Drugs Act to their pharma code of conduct. These new standards went into force effective October 1, 2019.
Watch on-demand to learn:
- How the regulations address product information, manufacturer responsibilities, and employee responsibilities
- What the implications are for social, digital, and mobile channels
- Why global companies should act quickly, instead of getting left behind
- How to take advantage of the business opportunity